Phase I Trial of MT-0169 in CD38+ Acute Leukemia With Relapsed/Refractory or Measurable Residual Disease
Clinical trial NCT06522373 · WITHDRAWN
Trial details
- NCT number
- NCT06522373
- Sponsor
- M.D. Anderson Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-21
- Primary completion
- 2024-10-21
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.